Victoria Navarro-Compán1, Ana Maria Gherghe2, Josef S Smolen2, Daniel Aletaha3, Robert Landewé3, Désirée van der Heijde3. 1. Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands, Department of Rheumatology, University Hospital La Paz, Madrid, Spain, Department of Rheumatology and Internal Medicine, Cantacuzino Clinical Hospital, Bucharest, Romania, Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Second Department of Medicine, Hietzing Hospital, Vienna, Austria and Amsterdam Rheumatology Center, Amsterdam, and Atrium Medical Center, Heerlen, The Netherlands Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands, Department of Rheumatology, University Hospital La Paz, Madrid, Spain, Department of Rheumatology and Internal Medicine, Cantacuzino Clinical Hospital, Bucharest, Romania, Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Second Department of Medicine, Hietzing Hospital, Vienna, Austria and Amsterdam Rheumatology Center, Amsterdam, and Atrium Medical Center, Heerlen, The Netherlands mvictoria.navarroc@gmail.com. 2. Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands, Department of Rheumatology, University Hospital La Paz, Madrid, Spain, Department of Rheumatology and Internal Medicine, Cantacuzino Clinical Hospital, Bucharest, Romania, Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Second Department of Medicine, Hietzing Hospital, Vienna, Austria and Amsterdam Rheumatology Center, Amsterdam, and Atrium Medical Center, Heerlen, The Netherlands Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands, Department of Rheumatology, University Hospital La Paz, Madrid, Spain, Department of Rheumatology and Internal Medicine, Cantacuzino Clinical Hospital, Bucharest, Romania, Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Second Department of Medicine, Hietzing Hospital, Vienna, Austria and Amsterdam Rheumatology Center, Amsterdam, and Atrium Medical Center, Heerlen, The Netherlands. 3. Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands, Department of Rheumatology, University Hospital La Paz, Madrid, Spain, Department of Rheumatology and Internal Medicine, Cantacuzino Clinical Hospital, Bucharest, Romania, Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Second Department of Medicine, Hietzing Hospital, Vienna, Austria and Amsterdam Rheumatology Center, Amsterdam, and Atrium Medical Center, Heerlen, The Netherlands.
Abstract
OBJECTIVE: The aim of this study was to investigate the relationship between different disease activity indices (DAIs) and their individual components and radiographic progression in patients with RA. METHODS: A systematic literature review until July 2013 was performed by two independent reviewers using the Medline and Embase databases. Longitudinal studies assessing the relationship between DAIs and single instruments and radiographic progression were included. The results were grouped based on the means of measurement (baseline vs time integrated) and analysis (univariable or multivariable). RESULTS: Fifty-seven studies from 1232 hits were included. All published studies that assessed the relationship between any time-integrated DAI including joint count and radiographic progression reached a statistically significant association. Among the single instruments, only swollen joint count and ESR were associated with radiographic progression, while no significant association was found for tender joint count. Data with respect to CRP are conflicting. Data on patient's global health, pain assessment and evaluator's global assessment are limited and do not support a positive association with progression of joint damage. CONCLUSION: Published data indicate that all DAIs that include swollen joints are related to radiographic progression while, of the individual components, only swollen joints and acute phase reactants are associated. Therefore composite DAIs are the optimal tool to monitor disease activity in patients with RA.
OBJECTIVE: The aim of this study was to investigate the relationship between different disease activity indices (DAIs) and their individual components and radiographic progression in patients with RA. METHODS: A systematic literature review until July 2013 was performed by two independent reviewers using the Medline and Embase databases. Longitudinal studies assessing the relationship between DAIs and single instruments and radiographic progression were included. The results were grouped based on the means of measurement (baseline vs time integrated) and analysis (univariable or multivariable). RESULTS: Fifty-seven studies from 1232 hits were included. All published studies that assessed the relationship between any time-integrated DAI including joint count and radiographic progression reached a statistically significant association. Among the single instruments, only swollen joint count and ESR were associated with radiographic progression, while no significant association was found for tender joint count. Data with respect to CRP are conflicting. Data on patient's global health, pain assessment and evaluator's global assessment are limited and do not support a positive association with progression of joint damage. CONCLUSION: Published data indicate that all DAIs that include swollen joints are related to radiographic progression while, of the individual components, only swollen joints and acute phase reactants are associated. Therefore composite DAIs are the optimal tool to monitor disease activity in patients with RA.
Authors: Jessica Wojciechowski; Michael D Wiese; Susanna M Proudman; David J R Foster; Richard N Upton Journal: Br J Clin Pharmacol Date: 2016-04-07 Impact factor: 4.335
Authors: Josef S Smolen; Ferdinand C Breedveld; Gerd R Burmester; Vivian Bykerk; Maxime Dougados; Paul Emery; Tore K Kvien; M Victoria Navarro-Compán; Susan Oliver; Monika Schoels; Marieke Scholte-Voshaar; Tanja Stamm; Michaela Stoffer; Tsutomu Takeuchi; Daniel Aletaha; Jose Louis Andreu; Martin Aringer; Martin Bergman; Neil Betteridge; Hans Bijlsma; Harald Burkhardt; Mario Cardiel; Bernard Combe; Patrick Durez; Joao Eurico Fonseca; Alan Gibofsky; Juan J Gomez-Reino; Winfried Graninger; Pekka Hannonen; Boulos Haraoui; Marios Kouloumas; Robert Landewe; Emilio Martin-Mola; Peter Nash; Mikkel Ostergaard; Andrew Östör; Pam Richards; Tuulikki Sokka-Isler; Carter Thorne; Athanasios G Tzioufas; Ronald van Vollenhoven; Martinus de Wit; Desirée van der Heijde Journal: Ann Rheum Dis Date: 2015-05-12 Impact factor: 19.103
Authors: Myrthe A M van Delft; Marije K Verheul; Leonie E Burgers; Veerle F A M Derksen; Annette H M van der Helm-van Mil; Diane van der Woude; Tom W J Huizinga; René E M Toes; Leendert A Trouw Journal: Arthritis Res Ther Date: 2017-08-15 Impact factor: 5.156